GMED - Globus Medical - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

GMED is currently covered by 15 analysts with an average price target of $102.58. This is a potential upside of $14.66 (16.67%) from yesterday's end of day stock price of $87.92.

Globus Medical's activity chart (see below) currently has 389 price targets and 293 ratings on display. The stock rating distribution of GMED is 20% HOLD and 80% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 92.29% with an average time for these price targets to be met of 305.45 days.

Highest price target for GMED is $123, Lowest price target is $70, average price target is $98.89.

Most recent stock forecast was given by VIK CHOPRA from WELLS FARGO on 26-Feb-2026. First documented stock forecast 17-Jun-2013.

Currently out of the existing stock ratings of GMED, 6 are a HOLD (20%), 24 are a BUY (80%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 07-Aug-2024

$104

$20.22 (24.13%)

$79

1 months 8 days ago
(26-Feb-2026)

12/14 (85.71%)

$7.29 (7.54%)

276

Buy Since 17-Jun-2013

$123

$39.22 (46.81%)

$114

1 months 9 days ago
(25-Feb-2026)

23/27 (85.19%)

$26.78 (27.83%)

337

Buy Since 30-Jan-2026

$114

$30.22 (36.07%)

$112

1 months 9 days ago
(25-Feb-2026)

3/5 (60%)

$17.78 (18.48%)

499

Buy Since 20-May-2024

$115

$31.22 (37.26%)

$90

2 months 26 days ago
(08-Jan-2026)

22/24 (91.67%)

$20.38 (21.54%)

325

Buy Since 07-Nov-2025

$105

$21.22 (25.33%)

$93

4 months 16 days ago
(18-Nov-2025)

33/34 (97.06%)

$21.58 (25.87%)

361

Show more analysts

Please expand the browser size to see the chart

What is GMED (Globus Medical) average time for price targets to be met?

On average it took 305.45 days on average for the stock forecasts to be realized with a an average price target met ratio 92.29

Which analyst has the current highest performing score on GMED (Globus Medical) with a proven track record?

MATT MIKSIC

Which analyst has the most public recommendations on GMED (Globus Medical)?

Matt Miksic works at BARCLAYS and has 6 price targets and 9 ratings on GMED

Which analyst is the currently most bullish on GMED (Globus Medical)?

Matt Miksic with highest potential upside - $39.22

Which analyst is the currently most reserved on GMED (Globus Medical)?

Bob Hopkins with lowest potential downside - -$46.78

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?